In the UK, NICE guidance (NG28) recommends considering GLP-1 receptor agonists for patients with type 2 diabetes according to specific criteria, typically when treatment with metformin and other oral medications has not achieved adequate glycaemic control
Helps prevent premature aging
Review dietary suitability: check each individual label for information relevant to vegetarian, vegan, allergen-aware or other dietary preferences
The narrow pocket of mTYR and the long side chain of CME limit the available conformations for CME during the docking process
Altimmune is developing a weekly obesity injection called pemvidutide, which targets GLP-1 and glucagon
Glutamine may help reduce symptoms by improving gut lining integrity, balancing the gut microbiota, and modulating inflammation